Clinical Trial Update: Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Tweet2Quit, a Twitter-enabled mobile messaging program, completed with results posted evaluating its effectiveness in preventing smoki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Snippet

Sponsor: University of California, Irvine | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2024-11-21